Lifeway Foods, Inc.
LWAY- Exchange
- Nasdaq
- Industry
- Dairy Products
- SEC CIK
- 0000814586
In the last 90 days, Lifeway Foods, Inc. insiders filed 2 open-market purchases and 2 sales; 96 institutions reported holding it in 13F filings for Q2 2026, worth $246.1M in total; no superinvestor holds it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Nov 13, 2026, 1:14 AM ET
Revenue flow, FY2025
Where the revenue went in FY2025, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jan 8, 2026 | Jan 6, 2025 | – | – | – |
| Revenue | $212.5M | $186.8M | $160.1M | $141.6M | $119.1M |
| Cost of revenue | $154.3M | $138.2M | $117.7M | $114.8M | $90.4M |
| Gross profit | $58.2M | $48.6M | $42.4M | $26.8M | $28.7M |
| Operating expenses | $42.0M | $34.7M | $25.4M | $24.4M | $22.8M |
| Selling, general and administrative | $21.6M | $19.4M | $13.1M | $12.6M | $11.6M |
| Operating income | $16.2M | $13.9M | $17.0M | $2.35M | $5.88M |
| Interest expense | – | – | $384.0K | $267.0K | $116.0K |
| Income tax | $5.83M | $4.94M | $5.28M | $917.0K | $2.31M |
| Net income | $13.9M | $9.03M | $11.4M | $924.0K | $3.31M |
| EPS, basic | $0.91 | $0.61 | $0.77 | $0.06 | $0.21 |
| EPS, diluted | $0.89 | $0.60 | $0.75 | $0.06 | $0.21 |
| Weighted shares, basic | 15.2M | 14.8M | 14.7M | 15.4M | 15.5M |
| Weighted shares, diluted | 15.5M | 15.1M | 15.1M | 15.7M | 15.8M |
| Margins and growth | |||||
| Gross margin | 27.4% | 26.0% | 26.5% | 18.9% | 24.1% |
| Operating margin | 7.6% | 7.4% | 10.6% | 1.7% | 4.9% |
| Net margin | 6.5% | 4.8% | 7.1% | 0.7% | 2.8% |
| Revenue growth, year over year | +13.7% | +16.7% | +13.1% | +18.9% | +16.7% |
| Net income growth, year over year | +53.6% | −20.6% | +1,130.2% | −72.1% | +2.4% |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jan 8, 2026 | Jan 6, 2025 | – | – | – |
| Cash and equivalents | $5.57M | $16.7M | $13.2M | $4.44M | $9.23M |
| Accounts receivable | $16.6M | $15.4M | $13.9M | $11.4M | $9.93M |
| Inventory | $11.9M | $8.68M | $9.10M | $9.63M | $8.29M |
| Total current assets | $37.1M | $43.6M | $38.2M | $27.0M | $29.0M |
| Property, plant and equipment | $48.3M | $26.9M | $22.8M | $20.9M | $20.1M |
| Goodwill | $11.7M | $11.7M | $11.7M | $11.7M | – |
| Intangible assets | $5.82M | $6.36M | $6.90M | $7.44M | $4.28M |
| Total assets | $105.6M | $90.5M | $81.7M | $69.0M | $70.9M |
| Accounts payable | $11.0M | $10.4M | $9.98M | $7.98M | $6.61M |
| Short-term debt | – | – | – | $1.25M | $1.00M |
| Total current liabilities | $16.6M | $15.5M | $16.6M | $13.0M | $12.1M |
| Long-term debt | – | – | $2.75M | $2.48M | $3.47M |
| Total liabilities | $19.8M | $18.6M | $21.2M | $21.4M | $21.7M |
| Shareholders' equity | $85.8M | $71.9M | $60.4M | $47.6M | $49.1M |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jan 8, 2026 | Jan 6, 2025 | – | – | – |
| Operating cash flow | $10.9M | $13.0M | $16.9M | $3.99M | $5.56M |
| Capital expenditures | $27.4M | $6.70M | $4.35M | $3.45M | $1.92M |
| Free cash flow | -$16.4M | $6.26M | $12.6M | $538.0K | $3.64M |
| Depreciation and amortization | $3.98M | $3.39M | $3.16M | $2.97M | $2.87M |
| Stock-based compensation | $1.95M | $2.45M | $1.50M | $1.11M | $1.14M |
| Share buybacks | – | – | $0 | $4.00M | $1.58M |
| Investing cash flow | -$22.0M | -$6.68M | -$4.41M | -$4.03M | -$7.14M |
| Financing cash flow | -$65.0K | -$2.75M | -$3.78M | -$4.75M | $2.88M |
| Ratio | |||||
| Stock-based compensation, % of revenue | 0.9% | 1.3% | 0.9% | 0.8% | 1.0% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.